Define cholesteatoma , etiology ( table) , pathology (chart form) , clinical features, investigation and management ( non pharmacology, pharmacology and surgical treatment ( name of surgery ( anaesthesia used, indications, preop , operative steps, post op of cholesteatoma

Reading File
Finding Sources
Finding Sources
Now let me read the main cholesteatoma sections from Cummings and KJ Lee's:
Reading File
Reading File
Reading File
Excellent data. Let me read more of the Cummings block31 for the detailed pathology, bone erosion, and management sections:
Reading File
Reading File
Reading File
Reading File
Let me read the key management and surgical sections:
Reading File
Reading File
Searching Images

cholesteatoma ear middle ear mastoid

I now have rich material from Cummings Otolaryngology. Let me read the surgical management section:
Reading File
I now have comprehensive information. Let me also quickly check the congenital cholesteatoma section and read the images:I now have all the information needed to compose a comprehensive answer. Let me synthesize everything.

CHOLESTEATOMA — Comprehensive Clinical Review

Sources: Cummings Otolaryngology Head and Neck Surgery; K.J. Lee's Essential Otolaryngology

1. DEFINITION

A cholesteatoma is an epidermal inclusion of the middle ear or mastoid — a cystic or sheet-like accumulation of keratinizing squamous epithelium within the middle ear cleft, filled with desquamated keratin debris. The term was coined by Johannes Müller in 1838 because the white-yellow keratin flakes grossly resemble cholesterol crystals (though cholesterol is actually present in only small amounts). Cruveilhier first described it as the "pearly tumor of the temporal bone" in 1829.
Key: Cholesteatoma is not a true neoplasm — it is a destructive, expansile epidermal cyst capable of eroding bone through osteoclast activation.

2. ETIOLOGY — TABLE

CategoryTypeMechanism
CongenitalPrimary congenital cholesteatomaEmbryonic epidermal cell rests trapped behind intact tympanic membrane; no prior otitis, no TM perforation
Acquired — PrimaryAttic retraction pocket (pars flaccida)Eustachian tube dysfunction → negative middle ear pressure → retraction and invagination of pars flaccida → accumulation of keratin
Acquired — SecondaryMigration through TM perforationSquamous epithelium migrates through a pre-existing central TM perforation (from CSOM) into the middle ear
Acquired — SecondaryTraumatic implantationTrauma or iatrogenic: squamous epithelium implanted into middle ear during surgery, foreign body, or fracture of temporal bone
Acquired — SecondaryMetaplasia theoryChronic inflammation → metaplastic transformation of middle ear mucosa into keratinizing squamous epithelium
Acquired — SecondaryEpithelial invasion/proliferationBasal keratinocyte hyperproliferation with enzymatic invasion through basement membrane
EAC typeExternal auditory canal cholesteatomaUlceration of EAC skin + necrosis of underlying bone (often posteroinferior EAC); distinct from middle ear cholesteatoma
Key predisposing factors: Eustachian tube dysfunction, cleft palate, poor mastoid pneumatization, chronic otitis media with effusion (OME), Down syndrome, craniofacial anomalies.

3. PATHOLOGY — CHART / FLOWCHART

3A. Structural Components

CHOLESTEATOMA
├── MATRIX (innermost layer)
│     └── Keratinizing squamous epithelium (hyperproliferative basal layer)
├── PERIMATRIX
│     └── Subepithelial fibrous connective tissue + inflammatory cells
│         (macrophages, lymphocytes, osteoclast precursors)
└── CONTENTS
      └── Laminated keratin debris (desquamated squames)

3B. Bone Erosion Mechanism (Pathophysiology Flowchart)

Squamous epithelium in confined space
        ↓
Accumulation of keratin debris → pressure + infection
        ↓
Keratin extrudes into perimatrix
        ↓
Inflammatory cascade activated
        ↓
RANKL ↑ on stromal cells & activated T-cells
        ↓
Osteoclastogenesis (RANK–RANKL pathway)
        ↓
Multinucleated osteoclasts recruited to bone surface
        ↓
Enzymatic bone resorption:
  • Acid phosphatase
  • Collagenase
  • Cathepsin-like proteases (pH ~4.0 microenvironment)
  • M-CSF upregulation
        ↓
BONE DESTRUCTION (intermittent, progressive)
  → Ossicular erosion (most common: long process of incus)
  → Scutum erosion
  → Tegmen erosion → intracranial extension
  → Labyrinthine fistula (horizontal SCC, 7–10% of cases)
  → Facial canal dehiscence
Note: Pressure necrosis theory (old) has been abandoned — measured cholesteatoma pressure (1.3–11.9 mmHg) never exceeds capillary perfusion pressure (~25 mmHg). Osteoclastic resorption is the established mechanism.

3C. Histopathology

  • Stratified squamous epithelium with active keratinization
  • Subepithelial fibrous tissue with chronic inflammatory infiltrate
  • Osteoclasts at bone interface (resorption lacunae)
  • No malignant transformation

4. CLINICAL FEATURES

Symptoms

FeatureDetails
OtorrheaChronic, recurrent, foul-smelling (malodorous — anaerobic bacteria), scanty but persistent
Hearing lossProgressive conductive hearing loss (ossicular erosion); mixed loss if labyrinthine fistula
OtalgiaMild, dull; acute pain if infected
VertigoIf labyrinthine (semicircular canal) fistula present
Facial palsyIf facial nerve canal eroded
AsymptomaticSome cases — especially early congenital

Signs on Otoscopy

SignDescription
Attic retraction pocketPars flaccida retraction with keratin debris (most common presentation of acquired cholesteatoma)
White pearly massBehind intact TM (congenital); visible white mass in attic
Keratin flakesWhite/cream cheesy material in external canal or behind TM
Granulation tissueAround the retraction pocket
Scutal erosionErosion of the lateral attic wall (pathognomonic sign on otoscopy)
Marginal perforationPosterosuperior or attic marginal perforation with cholesteatoma sac visible

Complications

IntratemporalIntracranial
Conductive/mixed hearing lossMeningitis
Labyrinthine fistulaExtradural abscess
LabyrinthitisSubdural abscess
Facial nerve palsyBrain abscess
Petrositis / Gradenigo syndromeLateral sinus thrombosis
TympanosclerosisOtitic hydrocephalus

5. INVESTIGATIONS

Clinical / Audiological

InvestigationFinding
Otoscopy / MicroscopyRetraction pocket, keratin debris, scutal erosion
Pure Tone Audiogram (PTA)Conductive or mixed hearing loss; degree reflects ossicular involvement
TympanometryType B or C curve (ET dysfunction); flat if ossicular fixation
Fistula test (Hennebert's test)Positive in labyrinthine fistula (nystagmus with pressure change)
Tuning fork testsRinne negative, Weber lateralized to affected ear

Imaging

ModalityIndication / Finding
HRCT Temporal BoneFirst-line imaging; shows soft tissue opacity in middle ear/mastoid, scutum erosion, ossicular destruction, tegmen/semicircular canal involvement, facial canal dehiscence
Non-echo-planar DWI-MRI (non-EPI DWI)Gold standard for detecting residual/recurrent cholesteatoma post-op; high sensitivity & specificity (meta-analysis confirms accuracy); cholesteatoma shows restricted diffusion
Gadolinium MRIDifferentiates cholesteatoma (no enhancement) from granulation tissue (enhances)
HRCT showing cholesteatoma with mastoid extension and ossicular erosion
HRCT temporal bone: top row — cholesteatoma without mastoid extension; bottom row — with mastoid extension showing soft tissue opacification of mastoid air cells and ossicular destruction
Intraoperative view of cholesteatoma
Intraoperative endoscopic view: A = mastoid bone; B = cholesteatoma fragments (yellowish-white keratinous debris); C = round window niche

6. MANAGEMENT

Non-Pharmacological (Conservative)

  • Aural toilet / Suction clearance: Microsuction or direct removal of entrapped keratin in clinic — delays surgery, prevents accumulation and infection
  • Saline irrigation: Irrigation to remove keratin from accessible retraction pockets
  • Water precautions: Avoid water entry into infected ear; ear plugs for bathing
  • Hearing aid: If hearing loss is significant and patient is not surgical candidate
  • Regular follow-up: Essential — cholesteatoma can expand silently; 6–12 monthly otoscopy + audiometry
Conservative treatment is NOT curative — it is a temporizing measure. Cholesteatoma can only be eradicated by surgery.

Pharmacological

DrugUse
Topical antibiotic drops (e.g., ciprofloxacin/ofloxacin)Treat superimposed infection, reduce otorrhea preoperatively
Topical acetic acidAcidification to reduce Pseudomonas/anaerobic colonization
Systemic antibiotics (e.g., amoxicillin-clavulanate, fluoroquinolones)Active infection, complications, pre-op preparation
Topical steroid-antibiotic combinationsReduce granulation tissue and inflammation around retraction pocket
IV antibioticsIntracranial complications (meningitis, brain abscess) — ceftriaxone ± metronidazole
1:3 dilute alcohol irrigationConservative topical antiseptic (listed in Cummings Box 140.2)

7. SURGICAL TREATMENT

Overview of Surgical Approaches

Surgery is the definitive treatment. Goals:
  1. Eradication of cholesteatoma (prevent recurrence/residual disease)
  2. Management of complications
  3. Hearing reconstruction (secondary)
Two groups of operations:
  • Resection & Reconstruction (canal-wall-up / CWU): cholesteatoma completely excised, ear canal rebuilt — includes attic resection, simple mastoidectomy, canal wall-up tympanomastoidectomy
  • Exteriorization (canal-wall-down / CWD): ear anatomy altered to externalize disease — radical mastoidectomy, modified radical mastoidectomy (MRM), Bondy procedure

SURGERY A: CANAL WALL-UP (CWU) TYMPANOMASTOIDECTOMY (Intact Canal Wall)

Details
AnaesthesiaGeneral anaesthesia (GA) with endotracheal intubation; hypotensive technique (MAP 60–70 mmHg) to reduce bleeding; facial nerve monitoring
IndicationsLimited cholesteatoma in middle ear/mastoid with good ET function; reliable patient who will comply with follow-up; desire to preserve normal ear canal anatomy; pediatric cases
PreoperativePure tone audiogram; HRCT temporal bone; audiological counseling; informed consent (risk of facial nerve injury, deafness, recurrence); treat active infection; hair shaving; NPO; anaesthetic assessment
Operative Steps:
  1. Patient supine, head turned, post-aural incision 1 cm behind pinna
  2. Elevation of periosteum, identification of spine of Henle and linea temporalis
  3. Cortical mastoidectomy: drill removal of mastoid cortex, opening mastoid antrum, identifying horizontal SCC and fossa incudis
  4. Antral exposure — identify short process of incus and lateral SCC
  5. Atticotomy — remove bone of lateral attic wall (scutum) to expose cholesteatoma in epitympanum
  6. Dissection of cholesteatoma matrix — meticulous removal preserving ossicles if possible; cholesteatoma traced posteriorly through mastoid
  7. Facial recess approach — drill posterior canal wall thinly, opening facial recess to expose sinus tympani and hypotympanum
  8. Check ossicular chain — remove matrix from ossicles, assess ossicular continuity
  9. Ossicular chain reconstruction (if needed): incus transposition, PORP/TORP prosthesis
  10. Tympanoplasty: temporalis fascia graft underlay/overlay repair of TM
  11. Cortical bone replaced or mastoid obliteration in selected cases
  12. Closure in layers; wool/cotton pack in canal
Postoperative:
  • Antibiotics (oral/IV per contamination)
  • Canal packing removed at 2–3 weeks
  • Audiogram at 6–8 weeks
  • Second-look surgery at 12 months to check for residual disease (or DWI-MRI as alternative)
  • Regular outpatient follow-up

SURGERY B: CANAL WALL-DOWN (CWD) — MODIFIED RADICAL MASTOIDECTOMY (MRM) / RADICAL MASTOIDECTOMY

Details
AnaesthesiaGeneral anaesthesia with endotracheal intubation; facial nerve monitoring mandatory; hypotensive anaesthesia
IndicationsExtensive cholesteatoma involving mastoid; revision cases; labyrinthine fistula; poor ET function; unreliable patient (won't return for follow-up); only-hearing ear (relative); petrous apex disease; sclerotic mastoid
Difference between Radical and Modified Radical:
  • Radical mastoidectomy: removes entire posterior canal wall + middle ear mucosa; obliterates middle ear; no hearing reconstruction possible
  • MRM (Bondy modification / standard MRM): posterior canal wall taken down, middle ear preserved where possible, TM remnant preserved, hearing reconstruction may be attempted
Preoperative:
  • HRCT temporal bone (essential for surgical planning)
  • PTA + speech audiometry
  • Informed consent: mastoid cavity, lifelong cleaning, water precautions, possible hearing loss, facial nerve risk
  • Treat active infection preoperatively with topical antibiotics
  • NPO, anaesthetic assessment, hair shaving
Operative Steps (MRM):
  1. Post-aural incision; periosteum elevated
  2. Mastoidectomy: all air cells exenterated, including tip cells, Trautmann's triangle
  3. Lowering of the facial ridge: posterior canal wall drilled down to level of facial nerve — key step that externalizes the middle ear
  4. Meatoplasty: enlarging the external meatus by removing conchal cartilage/skin to allow adequate cavity drainage and visualization
  5. Removal of cholesteatoma matrix from middle ear
  6. Saucerization: smoothing cavity walls to prevent ledges where epithelium can trap keratin
  7. Tympanoplasty (in MRM): temporalis fascia or perichondrium used to reconstruct TM remnant; middle ear reconstructed if possible
  8. In radical mastoidectomy: middle ear obliterated, Eustachian tube plugged
  9. Cavity left open; cavity packed with bismuth iodoform paraffin paste (BIPP) or similar
Postoperative:
  • Pack removal at 2–3 weeks
  • Cavity cleaning at 6 weeks, then 3-monthly
  • Lifelong periodic microsuction of cavity (accumulation of keratin, moisture)
  • Audiogram
  • Water precautions (ear protection when swimming/bathing)
  • No second-look surgery needed (cavity is externalized and directly visible)

SURGERY C: ENDOSCOPIC EAR SURGERY (EES) — Modern adjunct

Increasingly used for limited/attic cholesteatoma, provides superior visualization of sinus tympani and hypotympanum through a transcanal approach. Can be combined with microscopic mastoidectomy.

Surgical Decision Summary Table

FeatureCanal Wall-UpCanal Wall-Down
Residual disease rate11–27%2–10%
Recurrence rate5–13%Low
Second-look neededUsually yes (or DWI-MRI)Not required
Cavity problemsNoneCommon (lifelong cleaning)
Hearing outcomeBetterSlightly worse
Suitable forLimited disease, reliable ptExtensive disease, revision, complications

Key Points Summary

  • Cholesteatoma = destructive keratinizing squamous epithelial cyst; NOT a tumor
  • Bone erosion via RANKL-mediated osteoclastogenesis (not pressure necrosis)
  • Most common symptom: foul-smelling, scanty otorrhea
  • Most common ossicular erosion: long process of incus
  • Most common complication: labyrinthine fistula (horizontal SCC, 7–10%)
  • Investigation of choice for residual post-op disease: Non-EPI DWI-MRI
  • Definitive treatment: surgery only — no pharmacological cure
  • Most common surgical approach: canal wall-up (preserves anatomy) vs canal wall-down (lower recurrence, cavity problems)

Cummings Otolaryngology Head and Neck Surgery, pp. 2688–2695; K.J. Lee's Essential Otolaryngology, pp. 441–452Here is the complete, structured clinical review of cholesteatoma:

CHOLESTEATOMA — Comprehensive Clinical Review

Sources: Cummings Otolaryngology Head and Neck Surgery; K.J. Lee's Essential Otolaryngology

1. DEFINITION

A cholesteatoma is an epidermal inclusion of the middle ear or mastoid — a cystic or sheet-like accumulation of keratinizing squamous epithelium within the middle ear cleft, filled with desquamated keratin debris. The term was coined by Johannes Müller (1838) because the white-yellow keratin flakes grossly resemble cholesterol crystals. Cruveilhier first described it as the "pearly tumor of the temporal bone" (1829).
It is not a true neoplasm — it is a destructive, expansile epidermal cyst capable of eroding bone through osteoclast activation.

2. ETIOLOGY — TABLE

CategoryTypeMechanism
CongenitalPrimary congenital cholesteatomaEmbryonic epidermal cell rests trapped behind an intact tympanic membrane; no prior otitis media, no TM perforation
Acquired — PrimaryPars flaccida retraction pocketET dysfunction → chronic negative middle ear pressure → retraction + invagination of pars flaccida → keratin accumulates
Acquired — SecondaryEpithelial migration via TM perforationSquamous epithelium migrates through a pre-existing perforation (from CSOM) into the middle ear
Acquired — SecondaryTraumatic implantationSquamous epithelium implanted during trauma, surgery, temporal bone fracture, or foreign body
Acquired — SecondaryMetaplasia theoryChronic inflammation → metaplastic transformation of middle ear mucosa into keratinizing squamous epithelium
Acquired — SecondaryBasal cell proliferationHyperproliferative basal keratinocytes invade through basement membrane (invasion/proliferation theory)
EAC typeExternal auditory canal cholesteatomaUlceration of EAC skin + necrosis of posteroinferior EAC bone; distinct from middle ear cholesteatoma
Key predisposing factors: Eustachian tube dysfunction, cleft palate, underdeveloped mastoid pneumatization, chronic OME, Down syndrome, craniofacial anomalies (Treacher Collins), low socioeconomic status.

3. PATHOLOGY — CHART FORM

3A. Structural Components

CHOLESTEATOMA
├── MATRIX (inner lining)
│     └── Hyperproliferative keratinizing squamous epithelium
│         (basal layer shows increased mitotic activity)
│
├── PERIMATRIX (surrounding connective tissue)
│     └── Fibrous stroma with:
│         • Macrophages, lymphocytes, plasma cells
│         • Osteoclast precursor cells
│         • Fibroblasts, histiocytes
│         • RANKL-expressing stromal & T-cells
│
└── CONTENTS
      └── Laminated keratin debris (desquamated squames)
          + Small amounts of cholesterol crystals
          + Occasional anaerobic bacteria (if infected)

3B. Bone Erosion Mechanism — Pathophysiology Flowchart

Keratinizing squamous epithelium in confined middle ear space
                    ↓
     Keratin accumulation → expansion → infection
                    ↓
     Keratin extrudes into perimatrix subepithelium
                    ↓
         Inflammatory cascade activated
                    ↓
     RANKL ↑ on stromal cells & activated T-lymphocytes
     + M-CSF upregulation
                    ↓
     Osteoclastogenesis via RANK–RANKL–OPG axis
                    ↓
  Multinucleated osteoclasts recruited to bone surface
                    ↓
     Enzymatic bone resorption:
       • Acid phosphatase
       • Collagenase
       • Cathepsin-like proteases (pH ~4.0 microenvironment)
                    ↓
     PROGRESSIVE BONE DESTRUCTION (intermittent)
       → Ossicular erosion (most common: long process of incus)
       → Scutum erosion (attic wall)
       → Tegmen erosion → intracranial extension
       → Labyrinthine fistula (horizontal SCC — 7–10% of cases)
       → Facial canal dehiscence
       → Petrous apex involvement
Old theory (abandoned): Pressure necrosis — disproven because measured cholesteatoma pressure (1.3–11.9 mmHg) never exceeds capillary perfusion pressure (~25 mmHg). Osteoclastic resorption is the established mechanism.

3C. Histopathology

  • Stratified squamous epithelium with surface keratinization
  • Subepithelial chronic inflammatory infiltrate
  • Osteoclasts at bone interface with resorption lacunae (Howship's lacunae)
  • Endochondral otic capsule bone is relatively resistant to erosion compared to intramembranous bone of middle ear and mastoid

4. CLINICAL FEATURES

Symptoms

FeatureDetails
OtorrheaChronic, recurrent, malodorous (foul-smelling — anaerobic organisms); scanty but persistent; unresponsive to standard topical treatment
Hearing lossProgressive conductive hearing loss (ossicular erosion); mixed hearing loss if labyrinthine fistula develops
OtalgiaMild, dull; acute pain if superinfected
VertigoSuggests labyrinthine (semicircular canal) fistula
Facial palsySuggests facial nerve canal erosion
AsymptomaticCommon in early congenital cholesteatoma — found incidentally

Signs on Otoscopy / Microscopy

SignDescription
Attic retraction pocketPars flaccida retraction with keratin debris — most common otoscopic presentation
White pearly massBehind intact TM (congenital); or visible in attic
Keratin flakesWhite/cream cheesy material in external canal
Scutal erosionErosion of the lateral attic wall — pathognomonic sign
Marginal/attic perforationPosterosuperior or attic perforation with cholesteatoma sac visible
Granulation tissueAround retraction pocket or perforation edges

Complications

IntratemporalIntracranial
Conductive / mixed hearing lossMeningitis
Labyrinthine fistulaExtradural abscess
Labyrinthitis / sensorineural HLSubdural abscess
Facial nerve palsyBrain abscess
Petrositis / Gradenigo syndromeLateral sinus thrombosis
TympanosclerosisOtitic hydrocephalus
Gradenigo's triad (petrous apicitis): Deep facial/retro-orbital pain (V) + ipsilateral abducens palsy (VI) + otorrhea

5. INVESTIGATIONS

Audiological

TestExpected Finding
Pure Tone Audiogram (PTA)Conductive hearing loss (25–60 dB depending on ossicular involvement); mixed if labyrinthine fistula
TympanometryType B (flat) or Type C (negative pressure); flat trace with ossicular fixation
Tuning fork testsRinne negative (BC > AC), Weber lateralized to affected ear
Fistula test (Hennebert's test)Positive = nystagmus with tragal pressure → suggests labyrinthine fistula
Speech audiometryAssess communication impact

Imaging

ModalityIndication / Finding
HRCT Temporal Bone (1 mm slices, axial + coronal)First-line imaging; soft tissue opacity in middle ear/epitympanum/mastoid; scutum erosion; ossicular destruction; tegmen/SCC involvement; facial canal dehiscence; degree of mastoid pneumatization
Non-EPI DWI-MRI (non-echo-planar diffusion-weighted)Gold standard for detecting residual/recurrent cholesteatoma post-operatively; cholesteatoma shows restricted diffusion (high signal); meta-analysis confirms high sensitivity and specificity
Gadolinium-enhanced MRIDifferentiates cholesteatoma (non-enhancing) from granulation tissue (enhances)
Endoscopy / OtoendoscopyDirect visualization of retraction pockets, hidden recesses
HRCT temporal bone showing cholesteatoma with and without mastoid extension
HRCT temporal bone: top row = cholesteatoma without mastoid extension; bottom row = with mastoid extension showing soft tissue opacification of mastoid air cells and ossicular destruction
Coronal CT showing cholesteatoma with scutum erosion
Coronal CT temporal bone: large soft tissue opacity in middle ear/epitympanum, scutum erosion, ossicular chain disruption — classic radiological signs of acquired cholesteatoma

6. MANAGEMENT

A. Non-Pharmacological (Conservative)

MeasureDescription
Microsuction / Aural toiletRemoval of keratin debris in clinic under microscope; delays surgery, prevents infection
Saline irrigationIrrigation to clear accessible retraction pockets
Water precautionsEar plugs, avoid swimming; prevents water-triggered infections
Hearing aidIf significant hearing loss and patient is not surgical candidate
Regular surveillance6–12-monthly otoscopy + audiometry; essential even between treatments
Conservative management is temporizing only — cholesteatoma can only be cured by surgery.

B. Pharmacological

DrugIndication
Topical ciprofloxacin / ofloxacin dropsTreat superimposed infection; reduce otorrhea pre-operatively
Topical acetic acid (2%)Anti-Pseudomonal; acidification reduces anaerobic colonisation
Topical steroid-antibiotic combinationsReduce granulation tissue around retraction pocket
1:3 dilute alcohol irrigationAntiseptic; conservative topical management
Systemic antibiotics (amoxicillin-clavulanate, fluoroquinolones)Active infection, pre-op preparation, post-op prophylaxis
IV ceftriaxone ± metronidazoleIntracranial complications (meningitis, brain abscess)
Antivertiginous agentsSymptomatic vertigo (labyrinthine fistula)

C. Surgical Treatment

Surgery is the only definitive treatment. Goals:
  1. Complete eradication of cholesteatoma (primary)
  2. Management of complications
  3. Hearing reconstruction (secondary)

SURGERY 1: CANAL WALL-UP (CWU) TYMPANOMASTOIDECTOMY (Intact Canal Wall / Closed Technique)

ParameterDetails
AnaesthesiaGeneral anaesthesia, endotracheal intubation; hypotensive technique (MAP 60–70 mmHg); facial nerve monitoring (NIM) mandatory; muscle relaxant to be reversed before FN monitoring
IndicationsLimited cholesteatoma (attic/mesotympanum); good ET function; reliable patient for follow-up; pediatric patients; desire to preserve normal EAC anatomy
Pre-operativeHRCT temporal bone; PTA + speech audiometry; informed consent (facial nerve injury, deafness, recurrence, second-look surgery); treat active infection with topical ± systemic antibiotics; NPO 6–8 hrs; shave hair behind pinna; anaesthetic assessment; mark operative side
Operative Steps:
  1. Patient supine, head turned contralateral, arm abducted; post-aural skin incision 1 cm behind auriculocephalic sulcus
  2. Elevation of periosteum; identify spine of Henle (landmark for antrum) and linea temporalis
  3. Cortical mastoidectomy: systematic exenteration of mastoid air cells with continuous irrigation; identify mastoid antrum, horizontal (lateral) semicircular canal, fossa incudis, short process of incus, sigmoid sinus, tegmen
  4. Antrotomy: open antrum widely
  5. Atticotomy: remove lateral attic wall (scutum) bone to expose cholesteatoma in epitympanum
  6. Careful matrix dissection: methodical removal of cholesteatoma preserving ossicular chain if possible; trace posteriorly through antrum into mastoid
  7. Facial recess approach (posterior tympanotomy): thin posterior canal wall and drill facial recess (between facial nerve and chorda tympani) to expose sinus tympani, hypotympanum, round window
  8. Ossicular assessment: evaluate continuity; remove matrix from ossicular surfaces; preserve stapes superstructure
  9. Ossicular chain reconstruction (if needed): PORP (partial ossicular replacement prosthesis) or TORP (total), incus interposition, or stage for later reconstruction
  10. Tympanoplasty: temporalis fascia underlay graft to reconstruct TM; gelfoam packing in middle ear
  11. Canal packing: ribbon gauze or BIPP packing; skin closure with absorbable sutures; head bandage
Post-operative:
  • Oral antibiotics (5–7 days); analgesia; antiemetics
  • Canal packing removed at 2–3 weeks in clinic
  • Audiogram at 6–8 weeks
  • Second-look surgery at 12 months to detect residual disease (or DWI-MRI as non-invasive alternative)
  • Regular follow-up every 6 months

SURGERY 2: CANAL WALL-DOWN (CWD) — MODIFIED RADICAL MASTOIDECTOMY (MRM) / RADICAL MASTOIDECTOMY (Open Cavity / Exteriorization)

ParameterDetails
AnaesthesiaGeneral anaesthesia, endotracheal intubation; hypotensive technique; facial nerve monitoring mandatory
IndicationsExtensive cholesteatoma involving mastoid; revision surgery; poor ET function; labyrinthine fistula; only-hearing ear (relative); unreliable patient (cannot return for follow-up); sclerotic/poorly pneumatized mastoid; petrous apex involvement; intracranial complications
Difference — Radical vs. Modified Radical:
  • Radical mastoidectomy: posterior canal wall removed + middle ear mucosa stripped + TM removed; middle ear obliterated; Eustachian tube plugged; no hearing reconstruction — reserved for extreme disease
  • MRM (standard): posterior canal wall taken down, middle ear mucosa preserved where possible, TM remnant preserved, hearing reconstruction attempted
Pre-operative:
  • HRCT temporal bone (essential for surgical planning)
  • PTA + tympanometry; speech audiometry
  • Informed consent: mastoid cavity requiring lifelong cleaning, water precautions, possible permanent hearing loss, facial nerve risk, cavity problems (chronic discharge, recurrent infection)
  • Treat active infection preoperatively
  • NPO 6–8 hrs; anaesthetic assessment; mark operative side; hair shaving; IV antibiotics at induction
Operative Steps (MRM):
  1. Post-aural incision; periosteal elevation; identify landmarks (spine of Henle, linea temporalis, Macewen's triangle)
  2. Cortical mastoidectomy: complete air cell exenteration including tip cells, Trautmann's triangle (retrolabyrinthine cells); identify facial nerve, lateral SCC, sigmoid sinus, tegmen
  3. Lowering of the facial ridge: the posterior bony canal wall is drilled down flush with the level of the facial nerve — the key distinguishing step of canal-wall-down surgery; this externalizes the middle ear and mastoid into a single cavity
  4. Meatoplasty: conchal cartilage and/or skin removed to enlarge the external meatus adequately for cavity drainage, inspection, and cleaning; pinna sutured forward if necessary
  5. Removal of all cholesteatoma matrix from middle ear, epitympanum, mastoid
  6. Saucerization: all bony overhangs and ledges smoothed to create a self-cleansing, bowl-shaped cavity without recesses where keratin can re-accumulate
  7. Tympanoplasty (in MRM): temporalis fascia or perichondrium to reconstruct TM remnant; middle ear reconstructed if ET function adequate
  8. In radical mastoidectomy: middle ear obliterated; ET orifice plugged with muscle/fascia
  9. Cavity lined with a split-thickness skin graft or allowed to epithelialize spontaneously
  10. BIPP or ribbon gauze packing; wound closure; mastoid dressing
Post-operative:
  • IV/oral antibiotics; analgesia
  • Pack removal and first cavity inspection at 2–3 weeks
  • Cavity cleaning under microscope at 6 weeks, then every 3 months for life
  • Water precautions — ear plug always when bathing/swimming
  • Audiogram at 6–8 weeks; hearing aid if required
  • No second-look surgery needed — cavity is directly visible on clinic examination
  • Watch for cavity problems: persistent discharge, polyps, recurrent infection

SURGERY 3: ENDOSCOPIC EAR SURGERY (EES) — Modern Adjunct

Transcanal endoscopic approach used for:
  • Limited attic cholesteatoma (primary acquired, early congenital)
  • Superior visualization of sinus tympani, hypotympanum, anterior epitympanum
  • Avoids post-aural incision; can be combined with mastoidectomy (combined approach)

Surgical Decision Summary Table

FactorCanal Wall-Up (CWU)Canal Wall-Down (CWD)
Residual disease11–27%2–10%
Recurrence rate5–13%Rare
Second-look neededYes (or DWI-MRI)Not required
Cavity problemsNoneCommon (lifelong cleaning)
Hearing outcomeBetter preservedSlightly worse
Normal anatomyPreservedAltered
Best forLimited disease, reliable patientExtensive/revision, complications, unreliable follow-up

Quick Clinical Summary

PointKey Fact
DefinitionDestructive keratinizing squamous epithelial cyst — NOT a tumor
Bone erosion mechanismRANKL-mediated osteoclastogenesis (not pressure necrosis)
Most common symptomFoul-smelling, scanty, persistent otorrhea
Most common ossicular erosionLong process of incus
Pathognomonic otoscopic signAttic retraction with scutal erosion
Most common complicationLabyrinthine fistula (horizontal SCC, 7–10%)
Best post-op imagingNon-EPI DWI-MRI for residual/recurrent disease
Definitive treatmentSurgery only — no pharmacological cure
GA type usedGeneral anaesthesia with facial nerve monitoring
— Cummings Otolaryngology Head and Neck Surgery, pp. 2688–2695; K.J. Lee's Essential Otolaryngology, pp. 441–452
This is a shared conversation. Sign in to Orris to start your own chat.